Éric Dannaoui - Concepedia

Author

Éric Dannaoui

Also Known As

Arnaud Fekkar, Buot, G., D. Bouhour, Dannaoui, E., Dannaoui, Eric, Dannaoui, Éric, E DANNAOUI, E Dannaoui, E. DANNAOUI, E. DannaouI

282

Publications

14.2K

Citations

H-Index

113

Concepts

All Affiliations

Université Paris Cité Hôpital Européen Georges-Pompidou Assistance Publique – Hôpitaux de Paris Institut Pasteur Centre National de la Recherche Scientifique

ÉD

About

Éric Dannaoui is an author at Université Paris Cité specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	60	5.5K
2	Health Sciences	17	18	1.6K
3	Natural Sciences	6	6	487
4	Public Health	5	5	653
5	Social Sciences	1	1	59

Éric Dannaoui

125

Publications

10.2K

Citations

H-Index

Page 1

	Year	Citations
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 Oliver A. Cornely, Éric Dannaoui, Andreas H. Groll, Clinical Microbiology and Infection Clinical MycologyDermatologyMucormycosis 2013	2014	846
EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts J. L. Rodríguez-Tudela, Maiken Cavling Arendrup, Francesco Barchiesi, Clinical Microbiology and Infection Antifungal AgentDilution MicsAntifungal AgentsBioanalysisYeast	2008	644
A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007) Fanny Lanternier, Éric Dannaoui, Gloria Morizot, Clinical Infectious Diseases	2012	513
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others Anna Maria Tortorano, Malcolm Richardson, Emmanuel Roilides, Clinical Microbiology and Infection Diagnostic MycologyFungal PathogenPathologyClinical MycologyDermatology	2014	498
Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006 Dounia Bitar, Dieter Van Cauteren, Fanny Lanternier, Emerging infectious diseases Hospital RecordsDisease ManagementDiagnostic MycologyImmunodeficienciesPathogenesis	2009	423
Prospective Multicenter International Surveillance of Azole Resistance in<i>Aspergillus fumigatus</i> Jan W. M. van der Linden, Maiken Cavling Arendrup, Adilia Warris, Emerging infectious diseases Fungal DiversityClinical Aspergillus IsolatesAntifungal AgentAzole ResistanceHealth Sciences	2015	356
Invasive fungal diseases during COVID-19: We should be prepared Jean‐Pierre Gangneux, M.-E. Bougnoux, Éric Dannaoui, Journal de Mycologie Médicale Fungal VirusEmerging Infectious DiseasesInvasive Fungal DiseasesMicrobiologyInfection Control	2020	347
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi Anuradha Chowdhary, Jacques F. Meis, Josep Guarro, Clinical Microbiology and Infection Diagnostic MycologyFungal PathogenBlack FungiPathologyClinical Mycology	2014	346
In vitro susceptibilities of zygomycetes to conventional and new antifungals Éric Dannaoui Journal of Antimicrobial Chemotherapy Bioorganic ChemistryNew AntifungalsClinical MycologyAntimicrobial ChemotherapyDrug Resistance	2002	311
Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent? Ana Espinel‐Ingroff, Maiken Cavling Arendrup, Michael A. Pfaller, Antimicrobial Agents and Chemotherapy Diagnostic MycologyCandida SppClinical MycologyCollective Mic DataBioanalysis	2013	204

Page 1